MDM2 and cancer: To further validate the disruption of microRNA-mediated repression by RNA editing, we selected one cancer cell line with high RNA editing level (BT474) and one cell line (MDA-MB-231) with low RNA editing level at the 3′ UTR region of MDM2 (Table S5).